GSE168171 GSE168173 DDX41 knockdown U2OS 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE168171_GSE168173_DDX41 knockdown_U2OS_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE168171_GSE168173_DDX41 knockdown_U2OS_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE168171_GSE168173_DDX41 knockdown_U2OS_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE168171_GSE168173_DDX41 knockdown_U2OS_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

C-X-C motif chemokine ligand 8

Gene

aldo-keto reductase family 1 member C3

Gene

clusterin

Gene

activating transcription factor 3

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

aldo-keto reductase family 1 member C2

Gene

transmembrane 4 L six family member 1

Gene

MAGE family member A6

Gene

adhesion molecule with Ig like domain 2

Gene

amphiregulin

  • Gene

    C-X-C motif chemokine ligand 8


  • Gene

    aldo-keto reductase family 1 member C3



  • Gene

    activating transcription factor 3


  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    aldo-keto reductase family 1 member C2


  • Gene

    transmembrane 4 L six family member 1


  • Gene

    MAGE family member A6


  • Gene

    adhesion molecule with Ig like domain 2


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.